Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heinrich Mack (Heinrich Mack Nachf.) was a prominent German pharmaceutical company based in Illertissen, specializing in the development and manufacture of chemical-pharmaceutical products. Founded in the mid-19th century, the company became well-known for its expertise in antibiotics and respiratory treatments. In 1971, the company was acquired by Pfizer, serving as a strategic entry point for Pfizer's manufacturing and research operations in Germany. Today, the former Heinrich Mack headquarters in Illertissen remains one of Pfizer's most advanced global manufacturing sites, particularly noted for its highly automated production of solid dosage forms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heinrich Mack.